Study to Assess the Benefit of Midodrine in the Treatment of Patients With Neurogenic Orthostatic Hypotension
Status:
Completed
Trial end date:
2005-03-21
Target enrollment:
Participant gender:
Summary
The purpose of this clinical study is to evaluate the clinical effect of midodrine
hydrochloride (ProAmatine®) compared to placebo in patients with orthostatic hypotension by
measuring the time to onset of near syncopal symptoms and assessing several cardiovascular
measurements, such as heart rate, blood pressure, and ECG, using the tilt table test.